Key result
PFA matches cryoballoon ablation for 6-month arrhythmia recurrence, but cuts procedure time.
Why the study?
The study aimed to compare the efficacy and safety of the 2 most widely used single-shot ablation techniques worldwide, cryoballoon and pulsed field ablation, for symptomatic AF, representing the first PFA study published from Türkiye.
Does pulsed field ablation improve procedural efficiency and reduce 6-month atrial arrhythmia recurrence with comparable safety compared to cryoballoon ablation in patients with symptomatic atrial fibrillation?
Observational (n=100)
No
Does pulsed field ablation improve procedural efficiency and reduce 6-month atrial arrhythmia recurrence with comparable safety compared to cryoballoon ablation in patients with symptomatic atrial fibrillation?
In the first published experience from Türkiye comparing pulsed field ablation and cryoballoon ablation for symptomatic atrial fibrillation, pulsed field ablation achieved 100% acute pulmonary vein isolation with comparable 6-month arrhythmia freedom and safety, while significantly reducing procedure duration.
Answers are grounded in this paper and cite their sources.
Pulsed field ablation showed similar recurrence and shorter procedure times; leaves open whether randomized trials will confirm these observational findings in atrial fibrillation.
BACKGROUND: Catheter ablation is an effective treatment for patients with symptomatic atrial fibrillation (AF), and pulmonary vein isolation (PVI) is the cornerstone of AF ablation. Unlike thermal ablation, pulsed field ablation (PFA) uses nonthermal energy to irreversibly electroporate myocardial tissue without affecting adjacent structures such as the esophagus, phrenic nerve, and PV tissue. The aim of this study was to compare the efficacy and safety of the 2 most widely used single-shot ablation techniques worldwide: Cryoballoon (CB) and PFA. To date, this is the first PFA study to be published from Türkiye. METHODS: Consecutive AF patients who underwent PFA and CB-based PVI between July 2025 and February 2026 were enrolled. Cryoballoon PVI was performed using the 28-mm CB; PFA was performed using a 31 mm pentaspline catheter under fluoroscopic guidance. RESULTS: A total of 100 patients were included in the study (66% male, 64% with paroxysmal AF, mean age: 61.7 ± 11.8 years). There were 55 patients in the CB group and 45 patients in the PFA group. The skin-to-figure-of-8 time was significantly shorter in the PFA group than in the CB group (30.00 [25.00-35.00] vs. 53.00 [47.00-55.00] minutes, P < .001). No cerebrovascular events, groin complications, or pericardial effusions were observed in patients in either group. During the 6-month follow-up period, 4 (8.9%) cases of atrial arrhythmia were observed in the PFA group, compared to 7 (12.7%) in the CB group (P = .406). CONCLUSION: Both CB and PFA are safe and effective treatment methods for symptomatic patients diagnosed with AF. Compared to CB, acute procedure success rates and complications are similar in PFA, but procedure times are shorter.
No takes yet. Share an insight, caveat, or question.
Olgun et al. (2026) conducted an observational in Symptomatic atrial fibrillation (n=100). Pulsed field ablation (31 mm pentaspline Farawave catheter) vs. Cryoballoon ablation (28 mm Arctic Front Advance) was evaluated on Atrial arrhythmia recurrence during 6-month follow-up (p=0.406). Pulsed field ablation had similar 6-month atrial arrhythmia recurrence to cryoballoon ablation with shorter skin-to-figure-of-8 time.
Synapse has enriched 10 related papers. Consider them for comparative context: